Ubs Oconnor LLC Roivant Sciences Ltd. Transaction History

Ubs Oconnor LLC

$1.44 Billion
Q1 2025

A detailed history of Ubs Oconnor LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Ubs Oconnor LLC holds 42,819 shares of ROIV stock, worth $485,995. This represents 0.03% of its overall portfolio holdings.

Number of Shares

42,819

Holding current value

$485,995

% of portfolio

0.03%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$10.09 - $12.08 $1.38 Million - $1.65 Million	-136,447 Reduced 76.11%	42,819 $432,000
Q4 2024 Feb 14, 2025	BUY	$11.16 - $12.71 $360,791 - $410,901	32,329 Added 22.0%	179,266 $2.12 Million
Q3 2024 Nov 14, 2024	BUY	$10.17 - $12.5 $231,062 - $284,000	22,720 Added 18.29%	146,937 $1.7 Million
Q2 2024 Aug 14, 2024	BUY	$10.36 - $11.74 $279,720 - $316,980	27,000 Added 27.77%	124,217 $1.31 Million
Q1 2024 May 15, 2024	SELL	$9.87 - $11.8 $998,992 - $1.19 Million	-101,215 Reduced 51.01%	97,217 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$8.38 - $11.58 $286,771 - $396,279	34,221 Added 20.84%	198,432 $2.23 Million
Q3 2023 Nov 14, 2023	SELL	$9.76 - $13.19 $253,760 - $342,940	-26,000 Reduced 13.67%	164,211 $1.92 Million
Q2 2023 Aug 14, 2023	BUY	$7.09 - $10.08 $1.35 Million - $1.92 Million	190,211 New	190,211 $1.92 Billion
Q1 2023 May 15, 2023	BUY	$6.92 - $9.98 $133,729 - $192,863	19,325 Added 13.56%	161,825 $1.19 Million
Q4 2022 Feb 14, 2023	BUY	$3.36 - $7.99 $478,800 - $1.14 Million	142,500 New	142,500 $0

Others Institutions Holding ROIV

# of Institutions

336

Shares Held

495M

Call Options Held

3.67M

Put Options Held

754K

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $7.99B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account